Navamedic wins joint Nordic antibiotics tender

Oslo, 07 October 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals

READ MORE

Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has

READ MORE